- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04405635
Quantifying Digital Behavior on Smart Phones - Data From Stroke Survivors (QuantStroke)
December 6, 2023 updated by: University of Aarhus
In this study, we want to continuously record the interaction of 50 stroke survivors with their smartphones during the first 3 months after discharge.
The linkage of smart phone use to function and quality of life will be assessed with standardized outcome measures at defined time points.
Study Overview
Detailed Description
People with stroke are among the most relevant target groups for unobtrusive monitoring.
Worldwide, stroke is the second most frequent cause for lasting disability and causes a substantial burden for the individual, caregivers and society.
Thanks to improved treatment, many stroke survivors can be discharged to their homes.
However, many have to live with disabilities and are prone to declining function, cognitive impairment and depression.
With the acquired data, we want to create a database where digital behavior is analyzed with advanced computational methods.
In collaboration with the Department of Cognitive Psychology, University of Leiden, Netherlands, these data will be used to discover specific features for different health issues and to develop tools for the early detection of functional decline for different populations.
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Iris Brunner, PhD
- Phone Number: +4560568195
- Email: Iris.Brunner@rm.dk
Study Contact Backup
- Name: Jørgen Feldbæk Nielsen, PhD
Study Locations
-
-
Aarhus
-
Hammel, Aarhus, Denmark, 8450
- Recruiting
- Hammel neurorehabilitation centre and university research clinic
-
Contact:
- Iris Brunner, PhD
- Phone Number: +4560568195
- Email: Iris.Brunner@rm.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
We want to include a broad range of patients with stroke, incuding both ischemic and hemorrhagic strokes and different impairments due to stroke.
Patients are recruited at two wards specialized in neurorehabilitation around 1 week before discharge to their home.
Description
Inclusion Criteria:
- New or recurrent stroke, admitted to rehabilitation, discharge to own home
- Owns an Android smart phone
- Smart phone is used by the patient only
Exclusion Criteria:
- Severe cognitive impairments and / or psychiatric and behavioral conditions that interfere with compliance.
- Not able to provide informed consent
- Discharge to nursing homes or other care facilities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Different parameters of digital behavior
Time Frame: Continuously throughout the 90 days of monitoring
|
Number of interactions with the smart phone, tapping speed, typing speed, social media use
|
Continuously throughout the 90 days of monitoring
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EQ5D
Time Frame: Once a week during 12 weeks
|
Health related quality of life, 5 point subscale, Index values of 0-1 (better), EQ5D VAS 0-100 (better)
|
Once a week during 12 weeks
|
|
Mini MoCA
Time Frame: 3 times in three months, after 4, 8 and 12 weeks
|
Montreal Cognitive Assessment, cognitive function, scale 0-15 (better)
|
3 times in three months, after 4, 8 and 12 weeks
|
|
SF-36
Time Frame: 3 times in three months, after 4, 8 and 12 weeks
|
Health related quality of life, 0-100 (better)
|
3 times in three months, after 4, 8 and 12 weeks
|
|
Stroke Specific Quality of Life Questionnaire - short version
Time Frame: 3 times in three months, after 4, 8 and 12 weeks
|
Stroke related quality of life, 12-60 (better)
|
3 times in three months, after 4, 8 and 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health today
Time Frame: Every day throughout 90 days
|
One question about subjective health, VAS 0-100 (better)
|
Every day throughout 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Iris C. Brunner, PhD, Aarhus University, Hammel Neurocenter
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 30, 2020
Primary Completion (Estimated)
July 28, 2024
Study Completion (Estimated)
August 30, 2024
Study Registration Dates
First Submitted
May 26, 2020
First Submitted That Met QC Criteria
May 26, 2020
First Posted (Actual)
May 28, 2020
Study Record Updates
Last Update Posted (Actual)
December 7, 2023
Last Update Submitted That Met QC Criteria
December 6, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 614731
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Processed smartphone behavioral data and the associated processing codes will be made available upon publication and corresponding release in data repositories.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on No intervention or exposure
-
Albino MaiaCentro Hospitalar Lisboa Ocidental; Centro Hospitalar De São João, E.P.E.; Centro... and other collaboratorsRecruitingParkinson Disease | ManiaPortugal
-
Novoic LimitedTerminatedCognitive Impairment | Mild Cognitive ImpairmentUnited Kingdom
-
Guangdong Provincial People's HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruitingHCM - Hypertrophic CardiomyopathyChina
-
Ottawa Hospital Research InstituteUniversity of Toronto; University of Western Ontario, Canada; University of OttawaActive, not recruitingSleep Apnea Syndromes | Restless Legs Syndrome | Opioid Use | Risk Factors | Prognosis | Periodic Limb Movement Sleep Disorder | Polysomnography | Sleep Arousal DisordersCanada
-
IRCCS National Neurological Institute "C. Mondino...Institute of Biomedical Technologies-National Research Council (ITB-CNR)UnknownCognitive Dysfunction | Dietary HabitsItaly
-
Boston University Charles River CampusRecruiting
-
University of LiverpoolUniversity College London Hospitals; Oswaldo Cruz Foundation; Kamuzu University... and other collaboratorsCompletedDiseases of the Nervous System | Other Specified Viral DiseasesIndia, Brazil, Malawi
-
University of OxfordUniversity of Nottingham; Imperial College London; Public Health England; University... and other collaboratorsUnknown
-
KTO Karatay UniversityCompleted